HIMS Hims Hers Health Inc

P/E --
Forward P/E 73.53
Price/Sales 2.509
Beta 2.432
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Hims Hers Health is trading 5.4% down

Hims Hers Health is trading at $29.94, down 5.4% from a comparison close of $31.66 during regular trading. This is a price-action follow-up, so a separate...

πŸ”΄ Hims Hers Health is trading 5% down today

Hims Hers Health is trading 4.93% down at $30.10 on August 28, 2026, with no clearly attributable catalyst identified for the decline. - The move reverses the...

🟒 Hims Hers Health is trading 4.16% up today as Nvidia’s stronger outlook reinforces growth-stock buying

Hims Hers Health is trading 4.16% up now at $31.07 as U.S. equities rally, with the Nasdaq Composite up 1.36% and technology shares leading gains. - Nvidia’s...

πŸ”΄ Hims Hers Health is trading 4.09% down today after Visa placed it in Acquirer Monitoring Program

Hims Hers Health is trading 4.09% down at $30.45 as investors reassess payment and regulatory risks around its weight-loss subscriptions. - Visa placed the...

🟒 Hims Hers Health is trading 4.42% up today as Nasdaq rises 0.50%

Hims Hers Health is trading 4.42% up at $32.45, supported by broader market strength as the Nasdaq rises 0.50%. - The rebound follows Monday’s Visa-related...

FTC Takes Aim at Hims & Hers Over Billing and Privacy β€” Can the Telehealth Darling Weather a Federal Crackdown?

FTC Takes Aim at Hims & Hers Over Billing and Privacy β€” Can the Telehealth Darling Weather a Federal Crackdown?

Shares of Hims & Hers Health tumbled 8.0% to $31.09 on Monday as investors digested the weight of a Federal Trade Commission lawsuit that strikes at the core...

πŸ”΄ Hims Hers Health is trading 8% down today after renewed attention to FTC lawsuit

Hims Hers Health is trading at $31.09, down -7.96%, amid renewed attention to the Federal Trade Commission lawsuit. - The lawsuit alleges deceptive billing,...

🟒 Hims Hers Health is trading 4.09% up today as healthcare sector gains 1.29%

Hims Hers Health is trading at $33.16 (+4.09%), with the move appearing mainly sector-driven. - Healthcare rose 1.29% during regular trading. - Investors may...

🟒 Hims Hers Health is trading 5.86% up today amid healthcare-sector recovery

Hims Hers Health is trading 5.86% up now at $32.91, with the healthcare-sector recovery appearing to be the clearest explanation. - It gained 13.51% on August...

🟒 Hims Hers Health is trading 11% up today as healthcare stocks rebound after August 18 selloff

Hims Hers Health is trading 10.6% up at $30.28 as healthcare stocks rebound following the August 18 selloff. - Healthcare-sector ETF XLV is up 3.23%,...

🟒 Hims Hers Health is trading 4.7% up today on healthcare-sector gains after August 18 selloff

Hims Hers Health is trading 4.7% up at $28.67 in a rebound alongside a 1.90% healthcare-sector gain supported by positive cancer-vaccine trial news. - Shares...

πŸ”΄ Hims Hers Health is trading 4.18% down today on post-earnings margin concerns

Hims Hers Health is trading 4.18% down at $27.41 amid post-earnings concerns over its wider-than-expected second-quarter loss and margin pressure from branded...

πŸ”΄ Hims Hers Health is trading 4.1% down today after earnings release showed margin compression

Hims Hers Health is trading 4.1% down now at $29.27 after investors continued selling following the August 10 earnings release. - Revenue beat expectations at...

πŸ”΄ Hims Hers Health is trading 4.35% down today after sharply lower margins overshadowed higher revenue guidance

Hims Hers Health is trading 4.35% down at $30.39 after investors focused on the August 10 earnings miss and sharply lower margins. - Second-quarter revenue...

Hims & Hers Bets Big on Branded Weight-Loss Drugs, but Can Investors Stomach the Margin Hit

Hims & Hers Bets Big on Branded Weight-Loss Drugs, but Can Investors Stomach the Margin Hit

Shares of Hims & Hers Health tumbled 7.2% to $29.47 after the telehealth company reported a second-quarter loss that blindsided Wall Street, raising hard...

πŸ”΄ Hims Hers Health is trading 7.24% down in pre-market after GAAP loss misses expectations

Hims Hers Health is trading 7.24% down at $29.47 after its August 10, 2026 earnings release, as a GAAP loss of $0.37 per share missed the expected $0.05...

πŸ”΄ Hims Hers Health is trading 4.5% down in after-hours trading after a $0.37-per-share loss and margin contraction

Hims Hers Health is trading 4.53% down now at $30.33 after its second-quarter 2026 earnings release, with a $0.37-per-share loss and weaker margins driving the...

Hims & Hers beat second quarter revenue estimates but earnings missed amid margin contraction

Hims & Hers beat second quarter revenue estimates but earnings missed amid margin contraction

Hims & Hers Health reported second quarter 2026 revenue of $753.2 million, exceeding consensus estimates by approximately 8%. However, the company posted a...

Hims Hers Health Inc Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026

Analyst consensus expects Q2 2026 revenue of $698.9 million and an EPS loss of $0.07, with the current stock price of $31.59 trending above the average analyst...

🟒 Hims Hers Health is trading 5% up today after rebounding from FTC lawsuit losses

Hims Hers Health is trading 5.46% up now at $31.32 after rebounding from losses tied to the FTC lawsuit. β€’ The FTC alleges privacy violations, deceptive...